By the end of this course the participant should:
- Know important morphologic clues useful for the differential diagnosis of melanocytic tumors and understand the value as well as limitations of morphologic findings and clinical correlations.
- Be familiar with the spectrum of melanocytic nevi and melanoma variants.
- Understand the sensitivity and specificity of various novel methods (new immunohistochemical reagents, dermoscopy, cytogenetic and molecular tests) for the diagnosis of melanocytic tumors.
- Have a grasp of modern concepts in melanocyte pathology, with emphasis on pathologic, genomic and genetic correlations
- Know what is relevant to report and communicate to clinicians.
- Comprehend the role of the pathologist in determining treatment options for the patient through molecular and immunohistochemical analysis.
The course will be of value to dermatopathologists, general pathologists, dermatologists, and surgeons, as well as physicians in training.
Memorial Sloan Kettering Cancer Center designates this educational activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.